The Latest Breaking News from Schizophrenia

One pharmacist reported their patients waiting more than a week for a medication for bipolar and schizophrenia

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) on Wednesday released topline exploratory efficacy data from the SERENITY At-Home Pivotal Phase 3 safety trial, which demonstrated that BXCL501 had continued effects and consistent benefit with repeat dosing.

IN FULL

Amid a surge in research targeting cognitive disorders, the pharmaceutical industry is witnessing a wave of pivotal trial results that could reshape schizophrenia treatment paradigms. As biotech firms race to develop innovative therapies, Recognify Life Sciences steps into the spotlight with new findings from its latest clinical trial.

French researchers say they were able to treat ‘most deficits’ of schizophrenia in mice using llama antibodies

Habiba Naveed, who claims to be the secret daughter of Princess Diana, is now at the centre of controversy after allegedly assaulting her landlord. Here's what we know.

The Pentagon says people with congestive heart failure, undergoing treatment for schizophrenia or who have a history of paraphilic disorders will no longer be eligible for a medical waiver to serve in the military

Trapped under an abolished IPP jail term, Thomas White was driven to schizophrenia and psychosis. For the past year, The Independent has documented his tragic case – now he is finally being transferred to hospital following a six-year family campaign

An unusual collaboration between scientists and psychics could transform the treatment of auditory hallucinations